Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Abdullah Algaissi's research, publications, and ongoing work
Developed a pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike, demonstrating broad-spectrum antiviral potential.
Analyzed and reported on Saudi Arabia's preparedness and response to COVID-19, building on the country's prior experience with MERS.
Evaluated the side effects associated with COVID-19 vaccines in Saudi Arabia, providing crucial data for public health decision-making.
Demonstrated that immunization with an inactivated Middle East Respiratory Syndrome coronavirus vaccine can lead to lung immunopathology upon challenge with live virus, highlighting potential risks in vaccine design.
Showed rapid seroconversion and induction of specific antibody response in COVID-19 patients using SARS-CoV-2 S1 and N-based serological assays.
Identified that bacterial coinfections increase the mortality of severely ill COVID-19 patients in Saudi Arabia, emphasizing the importance of managing secondary infections.
Developed ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants as a potential therapeutic option for current and future coronavirus outbreaks.
Dr. Algaissi is a leading virologist and immunologist at Jazan University, specializing in vaccine development and immune responses to coronaviruses, including MERS-CoV and SARS-CoV-2, with significant contributions to understanding COVID-19 vaccine side effects and seroprevalence in Saudi Arabia.
Researchers with overlapping expertise and complementary work
Finding similar researchers...